Literature DB >> 22535795

The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction.

Christopher M O'Connor1, Robert J Mentz, Gad Cotter, Marco Metra, John G Cleland, Beth A Davison, Michael M Givertz, George A Mansoor, Piotr Ponikowski, John R Teerlink, Adriaan A Voors, Mona Fiuzat, Daniel Wojdyla, Karen Chiswell, Barry M Massie.   

Abstract

AIMS: In patients with acute heart failure (AHF), early worsening heart failure (WHF) predicts a significant proportion of post-discharge readmissions and mortality. We aimed to identify the predictors of 7-day heart failure events or death in patients hospitalized with AHF. METHODS AND
RESULTS: A predictive model and risk score for the short-term primary composite endpoint of 7-day death, HF rehospitalization, or WHF was created using variables collected within 24 h of admission from patients with complete data (n = 2015) enrolled in the PROTECT trial of AHF patients. The 7-day composite was experienced by 294 patients (14.6%), with a mortality rate of 1.8% (n = 37), HF rehospitalization rate of 0.5% (n = 9), and WHF rate of 13.1% (n = 264). In multivariable analyses, the strongest predictor of short-term morbidity and mortality was higher blood urea nitrogen (BUN) concentration. Additional independent predictors of a worse outcome were lower serum albumin, cholesterol, and systolic blood pressure, as well as higher heart rate and respiratory rate. Model coefficients were converted to an additive risk score for predicting the 7-day composite endpoint with a total point range of 0-100. The risk score allowed discrimination of a wide spectrum of risk (4.8% risk with score ≤35, to 28.7% risk with score >55).
CONCLUSIONS: Using the PROTECT 7-day risk model and score, the main determinants of an adverse outcome for AHF patients included impaired metabolic status, neurohormonal activation, and reduced cardiac performance, gauged by BUN, serum albumin and cholesterol levels, systolic blood pressure, heart rate, and respiratory rate.

Entities:  

Mesh:

Year:  2012        PMID: 22535795     DOI: 10.1093/eurjhf/hfs029

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  41 in total

Review 1.  Pathophysiology and clinical evaluation of acute heart failure.

Authors:  Robert J Mentz; Christopher M O'Connor
Journal:  Nat Rev Cardiol       Date:  2015-09-15       Impact factor: 32.419

2.  Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF.

Authors:  Marat Fudim; Christopher M O'Connor; Allison Dunning; Andrew P Ambrosy; Paul W Armstrong; Adrian Coles; Justin A Ezekowitz; Stephen J Greene; Marco Metra; Randall C Starling; Adriaan A Voors; Adrian F Hernandez; G Michael Felker; Robert J Mentz
Journal:  Eur J Heart Fail       Date:  2017-10-29       Impact factor: 15.534

Review 3.  Therapeutic Advances in the Management of Acute Decompensated Heart Failure.

Authors:  Elena-Laura Antohi; Andrew P Ambrosy; Sean P Collins; Ali Ahmed; Vlad Anton Iliescu; Gad Cotter; Peter S Pang; Javed Butler; Ovidiu Chioncel
Journal:  Am J Ther       Date:  2019 Mar/Apr       Impact factor: 2.688

4.  Creation and validation of the acute heart failure risk score: AHFRS.

Authors:  Susana Garcia-Gutierrez; José Maria Quintana; Ane Antón-Ladislao; Maria Soledad Gallardo; Esther Pulido; Irene Rilo; Elena Zubillaga; Miren Morillas; José Juan Onaindia; Nekane Murga; Ricardo Palenzuela; José González Ruiz
Journal:  Intern Emerg Med       Date:  2016-10-11       Impact factor: 3.397

Review 5.  Noncardiac comorbidities and acute heart failure patients.

Authors:  Robert J Mentz; G Michael Felker
Journal:  Heart Fail Clin       Date:  2013-05-23       Impact factor: 3.179

6.  Worsening heart failure during hospitalization for acute heart failure: Insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF).

Authors:  Jacob P Kelly; Robert J Mentz; Vic Hasselblad; Justin A Ezekowitz; Paul W Armstrong; Faiez Zannad; G Michael Felker; Robert M Califf; Christopher M O'Connor; Adrian F Hernandez
Journal:  Am Heart J       Date:  2015-04-15       Impact factor: 4.749

Review 7.  The Impact of Worsening Heart Failure in the United States.

Authors:  Lauren B Cooper; Adam D DeVore; G Michael Felker
Journal:  Heart Fail Clin       Date:  2015-08-11       Impact factor: 3.179

Review 8.  Epidemiology and importance of renal dysfunction in heart failure patients.

Authors:  Gregory Giamouzis; Andreas P Kalogeropoulos; Javed Butler; Georgios Karayannis; Vasiliki V Georgiopoulou; John Skoularigis; Filippos Triposkiadis
Journal:  Curr Heart Fail Rep       Date:  2013-12

Review 9.  Predicting mortality in patients with acute heart failure: Role of risk scores.

Authors:  Andrea Passantino; Francesco Monitillo; Massimo Iacoviello; Domenico Scrutinio
Journal:  World J Cardiol       Date:  2015-12-26

10.  Anti-oxidative and cholesterol efflux capacities of high-density lipoprotein are reduced in ischaemic cardiomyopathy.

Authors:  Parin J Patel; Amit V Khera; Robert L Wilensky; Daniel J Rader
Journal:  Eur J Heart Fail       Date:  2013-05-24       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.